Literature DB >> 12570796

The role of melanocortin peptides and receptors in regulation of energy balance.

Ildiko Antal Zimanyi1, Mary Ann Pelleymounter.   

Abstract

Energy balance is a highly regulated, complex process which is modulated by central and peripheral systems. Dysregulation of energy homeostasis can result in metabolic disorders, such as obesity and type II diabetes. Obesity and type II diabetes are two of the most prevalent and challenging clinical conditions in society today. A growing body of evidence has implicated the melanocortin system as an important component in the maintenance of energy balance. alpha-MSH, a 13 amino acid peptide secreted as a product of the pro-opiomelanocortin (POMC) gene in the pituitary is a potent agonist of 4 of the 5 cloned melanocortin receptors (MCR). MC receptors are members of a G-protein-coupled receptor (GPCR) family, which signal through cAMP. Agouti and agouti-related protein (AGRP) are natural antagonists of melanocortin receptors and participate in regulation of skin/fur pigmentation, body weight, and adiposity. Stimulation of MC receptors has pleiotropic effects, which impact the nervous system as well as endocrine and immune functions. One of the most prominent effects of MC receptor stimulation is a dramatic suppression of food intake and body weight, which has led to the hypothesis that the MC receptor system plays a primary role in the maintenance of energy balance. This idea is supported by a large body of pharmacological, molecular and human genetic evidence. The following review summarizes the role of melanocortin receptors in the regulation of food intake and energy homeostasis and highlights the opportunities for MC receptors as drug development targets in treating eating disorders and diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570796     DOI: 10.2174/1381612033391234

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  12 in total

1.  Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.

Authors:  Alexander V Mayorov; So-Yeop Han; Minying Cai; Matthew R Hammer; Dev Trivedi; Victor J Hruby
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

2.  Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Authors:  Alexander V Mayorov; Minying Cai; Kevin B Chandler; Ravil R Petrov; April R Van Scoy; Zerui Yu; Dustin K Tanaka; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

Review 3.  Participation of the central melanocortin system in metabolic regulation and energy homeostasis.

Authors:  Jin Kwon Jeong; Jae Geun Kim; Byung Ju Lee
Journal:  Cell Mol Life Sci       Date:  2014-06-04       Impact factor: 9.261

Review 4.  Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology.

Authors:  Steven L Shipp; Mark A Cline; Elizabeth R Gilbert
Journal:  Adipocyte       Date:  2016-07-13       Impact factor: 4.534

5.  Complex catabolic effects of central alpha-MSH infusion in rats of altered nutritional states: differences from leptin.

Authors:  Szilvia Soos; Erika Petervari; Miklos Szekely; Andrea Jech-Mihalffy; Marta Balasko
Journal:  J Mol Neurosci       Date:  2010-10-15       Impact factor: 3.444

6.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

Review 7.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

Review 8.  The role of the Agouti-Related Protein in energy balance regulation.

Authors:  O Ilnytska; G Argyropoulos
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

9.  Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.

Authors:  Hongchang Qu; Minying Cai; Alexander V Mayorov; Paolo Grieco; Morgan Zingsheim; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

10.  Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Matthew M Dedek; James P Cain; April R Van Scoy; Bahar Tan; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2007-12-19       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.